SpeeDx, Serosep sign dis­tri­bu­tion agree­ment

BioSpectrum (Asia) - - SUPPLIER NEWS -

Australia based SpeeDx has an­nounced a dis­tri­bu­tion agree­ment with Serosep Ltd, a lead­ing man­u­fac­turer and dis­trib­u­tor of lab­o­ra­tory di­ag­nos­tic so­lu­tions. This will strengthen sales chan­nels in the UK and

Ire­land, en­sur­ing greater ac­cess to SpeeDx’s mul­ti­plexed PlexPCR and Re­sis­tancePlus molec­u­lar di­ag­nos­tic tests across the re­gion. The agree­ment pro­vides Serosep cus­tomers with ac­cess to SpeeDx’s pro­pri­etary tech­nol­ogy for in­fec­tious dis­ease di­ag­nos­tics, in line with Serosep’s goal of im­prov­ing lives while sup­port­ing the ev­ery­day strug­gles faced by lab­o­ra­to­ries.

The SpeeDx port­fo­lio in­cludes the mar­ket-lead­ing Re­sis­tancePlus MG as­say for si­mul­ta­ne­ous de­tec­tion of My­coplasma gen­i­tal­ium and ge­netic mark­ers for azithromycin re­sis­tance as well as a mul­ti­plex test for her­pes sim­plex virus (1 and 2), vari­cella zoster and Tre­ponema pal­lidum (syphilis). Fur­ther Re­sis­tancePlus as­says will be re­leased later this year in­clud­ing a test for gon­or­rhoea along with a com­pre­hen­sive PlexPCR mul­ti­plex panel for res­pi­ra­tory virus test­ing.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.